widaplik

Generic: telmisartan, amlodipine and indapamide

Labeler: azurity pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name widaplik
Generic Name telmisartan, amlodipine and indapamide
Labeler azurity pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

amlodipine besylate 5 mg/1, indapamide 2.5 mg/1, telmisartan 40 mg/1

Manufacturer
Azurity Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 24338-003
Product ID 24338-003_a30ff81d-420b-40ea-83d8-670260a93fff
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA219423
Listing Expiration 2026-12-31
Marketing Start 2025-10-20

Pharmacologic Class

Established (EPC)
angiotensin 2 receptor blocker [epc] thiazide-like diuretic [epc]
Mechanism of Action
angiotensin 2 receptor antagonists [moa]
Physiologic Effect
increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 24338003
Hyphenated Format 24338-003

Supplemental Identifiers

RxCUI
2727452 2727458 2727460 2727462 2727463 2727465
UPC
0324338003305 0324338001301
UNII
864V2Q084H U5SYW473RQ F089I0511L
NUI
N0000000070 N0000175561 N0000175359 N0000175420

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name widaplik (source: ndc)
Generic Name telmisartan, amlodipine and indapamide (source: ndc)
Application Number NDA219423 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
  • 2.5 mg/1
  • 40 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (24338-003-30)
source: ndc

Packages (1)

24338-003-30 30 TABLET in 1 BOTTLE (24338-003-30)

Ingredients (3)

amlodipine besylate (5 mg/1) indapamide (2.5 mg/1) telmisartan (40 mg/1)

Linked Drug Pages (1)

WIDAPLIK ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a30ff81d-420b-40ea-83d8-670260a93fff", "openfda": {"nui": ["N0000000070", "N0000175561", "N0000175359", "N0000175420"], "upc": ["0324338003305", "0324338001301"], "unii": ["864V2Q084H", "U5SYW473RQ", "F089I0511L"], "rxcui": ["2727452", "2727458", "2727460", "2727462", "2727463", "2727465"], "spl_set_id": ["a30ff81d-420b-40ea-83d8-670260a93fff"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]", "Thiazide-like Diuretic [EPC]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Azurity Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (24338-003-30)", "package_ndc": "24338-003-30", "marketing_start_date": "20251020"}], "brand_name": "WIDAPLIK", "product_id": "24338-003_a30ff81d-420b-40ea-83d8-670260a93fff", "dosage_form": "TABLET", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]", "Increased Diuresis [PE]", "Thiazide-like Diuretic [EPC]"], "product_ndc": "24338-003", "generic_name": "telmisartan, amlodipine and indapamide", "labeler_name": "Azurity Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "WIDAPLIK", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "INDAPAMIDE", "strength": "2.5 mg/1"}, {"name": "TELMISARTAN", "strength": "40 mg/1"}], "application_number": "NDA219423", "marketing_category": "NDA", "marketing_start_date": "20251020", "listing_expiration_date": "20261231"}